Home › Free Stock Grades › ADGI
Adagio Therapeutics, Inc. (ADGI) Stock Grade
ADGI · Healthcare
C
Market Cap
$505.7M
P/E Ratio
—
Revenue Growth (YoY)
+110.5%
Net Margin
-98.3%
Return on Equity
—
Dividend Yield
None
About Adagio Therapeutics, Inc.'s fundamentals
Adagio Therapeutics is a biotechnology company with a market capitalization of $505.7 million that demonstrated strong revenue growth of 110.5% year-over-year, indicating expanding commercial traction. However, the company operates at a significant loss, with a net margin of -98.3%, meaning it is currently spending substantially more than it generates in revenue. The company does not pay a dividend, and traditional valuation metrics like P/E ratio and return on equity are not applicable given the ongoing losses.